NCT07104266
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07104266
Title Triple Negative Breast Cancer and Celecoxib. Pilot Study
Recruitment Recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors Universite de Sherbrooke
Indications
Therapies
Age Groups: adult | senior
Covered Countries CAN


No variant requirements are available.